Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2300234	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-12-21		Gan & Lee Pharmaceuticals			view
CYSB2300203	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-11-03		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSZ2200062	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2022-11-08					view
JYSZ2200061	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2022-11-08					view
CYSB2200233	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2022-09-23		Gan & Lee Pharmaceuticals			view
CXSS2200010	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products(3.3)	New Drug Application	2022-01-28		Yichang HEC Changjiang Pharmaceutical Co Ltd			view
CYSB2101284	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-12-10		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSB2101173	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-11-29		Lilly France			view
JYSB2101175	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-11-29		Lilly France			view
CYSB2101244	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-10-28		Lilly Suzhou Pharmaceutical Co Ltd			view
CYSB2101174	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-09-02		Zhuhai United Laboratories Co Ltd			view
CYSB2101062	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-05-19		Zhuhai United Laboratories Co Ltd			view
JYSZ2100516	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-05-12					view
JYSZ2100506	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21					view
JYSZ2100505	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21					view
JYSZ2100508	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21					view
JYSZ2100507	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21					view
JYSB2000673	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-15	view
JYSB2000672	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-15	view
JYSB2000669	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-15	view